SCHEMBL25650688

SCHEMBL25650688

COC(C)COc1nc2c(ccn2C(C)(C)c2cc3c(F)c[nH]c3nc2OCC(C)OC)cc1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25624436 0.86 GRM4 (0.33) —
SCHEMBL25624363 0.74 MAPK1 (0.31) —
SCHEMBL25650687 0.71 KDR (0.31) —
SCHEMBL25624362 0.71 CDK1 (0.34) —
SCHEMBL25625569 0.70 FGFR1 (0.35) —
SCHEMBL25624434 0.70 MERTK (0.35) —
SCHEMBL25626737 0.69 LRRK2 (0.34) —
SCHEMBL25627364 0.69 MAP3K7 (0.33) —
SCHEMBL25626807 0.69 HTR2C (0.35) —
SCHEMBL25650927 0.68 CDK1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159527-A1 COMPOUNDS AS BCL-2 INHIBITORS FOCHON BIOSCIENCES, LTD. (CN) 2023-05-25 — — US disclosed
Send feedback